Biocom Medical Device Workshop: Reimbursement Seminar and Update

Social Share:

When:

Thu Feb 14 16:00:00 GMT 2019 - Thu Feb 14 19:30:00 GMT 2019

Where:

Does your company need to catch up on reimbursement issues? Join Biocom for this in-depth instructional seminar that will review the pathways in reimbursement, discuss the latest case studies, and provide an update on the latest payer developments.

Presented by Stephen Hull, Founder and Principal of Hull Associates, with a guest presentation by Matt Reifenberger, PhD, Edwards Lifesciences

Key seminar topics:

·  Overview of the latest trends in Medicare and commercial coverage, coding, & payment, and of other public and private sector plan and reimbursement schemes
·  Review of a successful case study:  Edwards Lifesciences Rapid Deployment heart valve
·  What are the key success factors for reimbursement for medical technology (devices, diagnostics, and combination products)?
·  What major categories of different reimbursement structures exist outside of the US? How should a reimbursement professional contemplate the OUS market?
·  What strategies exist, and are there logical sequences of countries or regions that help leverage prior evidence and experience?
·  How should companies design evidence strategies that successfully bridge the US FDA requirements with needs of payers around the world.

The seminar will be structured as a primer and update with take home instructional slides on the following topics:

I.  Overview of Core Concepts: Coverage, Coding and Payment
II. Evidence and Coverage: How to bridge FDA and Payer requirements
III. Edwards Lifesciences: Key examples of navigating pathways for coverage, coding and payment
IV.  US Medicare reimbursement systems
   a. Inpatient DRGs
   b. Outpatient APCs
   c. Physician Fee Schedule
   d. Clinical lab fee schedule; DME fee schedule, etc.
V. US Commercial Payer Overview
VI. International Markets: EU-5 and Japan
VII. Wrap up and conclusions.

Presenters:
Stephen Hull, Principal and Founder, Hull Associates, LLC
Matt Reifenberger, PhD, Sr. Manager, Global Health Economics and Reimbursement, Edwards Lifesciences
*Expand tab below to learn more about our speakers

Agenda:
8:00am to 8:30am | Registration and Networking
8:30am to 11:30am | Event Workshop

*Breakfast and coffee will be provided

Biocom Member

Today's Price: 0.0

Important Dates	Amount
Registration before
Registration before
Registration before
	0.0
Refund before Fri Feb 01 00:00:00 GMT 2019	0.0
Refund before
Refund Before
*Refunds will no longer be accepted after

Non-Member (Industry Only)

Today's Price: 25.0

Important Dates	Amount
Registration before
Registration before
Registration before
	25.0
Refund before Fri Feb 01 00:00:00 GMT 2019	25.0
Refund before
Refund Before
*Refunds will no longer be accepted after

Meet Our Speakers

Stephen Hull, Principal and Founder, Hull Associates LLC
Stephen Hull has over 25 years of experience in health policy and medical product strategy, for medical devices and diagnostics, as well as pharmaceuticals and biotech products. He is Principal and Founder of Hull Associates, a specialized global reimbursement strategy firm focused on medical device and diagnostic technologies. With 40 seasoned consultants worldwide, his firm routinely assists in the development and execution of comprehensive strategies for product launch and reimbursement in major global markets. Prior to forming Hull Associates, he served as Sr. Vice President for Global Reimbursement at AdvaMed, in Washington, D.C., the leading U.S.-based medical technology trade association. In that capacity, he worked with every major medical device company in the industry for common reimbursement policy issues in all major therapeutic areas. Internationally, he designed and launched numerous joint advocacy campaigns, with a primary focus on reimbursement issues, working with sister associations in the major overseas markets. Before his trade association work, Mr. Hull was a Principal at Covance Health Economics and Outcomes Services, where he executed numerous private and public payor reimbursement and market strategies for pharmaceutical, biotech and medical device products, from nephrology, cardiology and oncology, to treatments for obesity and ophthalmic indications. Mr. Hull has served in the past as a committee chair for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is a frequent speaker at industry seminars on reimbursement issues internationally. He has an advanced degree in health policy from the Johns Hopkins Bloomberg School of Public Health, and a bachelor’s degree in international relations and French from Colgate University.

Matt Reifenberger, Sr. Manager, Global Health Economics and Reimbursement, Edwards Lifesciences
Matt Reifenberger is currently a Sr. Manager on the Global Health Economics and Reimbursement team at Edwards Lifesciences. Since joining in 2015, he has helped drive reimbursement, health economic, market access, evidence generation, and health policy strategies for Edward Lifesciences surgical products. During this time he has developed a wide range of economic and reimbursement collateral and messaging to support global product launches. In addition, he has successfully obtained and implemented a New Technology Add-on Payment (NTAP) for a rapid deployment surgical aortic heart valve and a new Category III CPT Code for a novel mitral repair device. Prior to Joining Edwards Lifesciences he spent 4 years at Hull Associates developing reimbursement and markets access strategies for a wide range of medical device and pharmaceutical clients. From West Lafayette Indiana originally, Matt holds Exercise Physiology and Medical Physiology degrees from the University of Indiana (’02), the University of Georgia (’04), and the University of Missouri (’08). He currently lives in Aliso Viejo, California with his wife Darcy and two daughters, Ellie and Emily.

a0d5A00000LDDOzQAP
Go

Meet Our Speakers

Stephen Hull, Principal and Founder, Hull Associates LLC
Stephen Hull has over 25 years of experience in health policy and medical product strategy, for medical devices and diagnostics, as well as pharmaceuticals and biotech products. He is Principal and Founder of Hull Associates, a specialized global reimbursement strategy firm focused on medical device and diagnostic technologies. With 40 seasoned consultants worldwide, his firm routinely assists in the development and execution of comprehensive strategies for product launch and reimbursement in major global markets. Prior to forming Hull Associates, he served as Sr. Vice President for Global Reimbursement at AdvaMed, in Washington, D.C., the leading U.S.-based medical technology trade association. In that capacity, he worked with every major medical device company in the industry for common reimbursement policy issues in all major therapeutic areas. Internationally, he designed and launched numerous joint advocacy campaigns, with a primary focus on reimbursement issues, working with sister associations in the major overseas markets. Before his trade association work, Mr. Hull was a Principal at Covance Health Economics and Outcomes Services, where he executed numerous private and public payor reimbursement and market strategies for pharmaceutical, biotech and medical device products, from nephrology, cardiology and oncology, to treatments for obesity and ophthalmic indications. Mr. Hull has served in the past as a committee chair for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is a frequent speaker at industry seminars on reimbursement issues internationally. He has an advanced degree in health policy from the Johns Hopkins Bloomberg School of Public Health, and a bachelor’s degree in international relations and French from Colgate University.

Matt Reifenberger, Sr. Manager, Global Health Economics and Reimbursement, Edwards Lifesciences
Matt Reifenberger is currently a Sr. Manager on the Global Health Economics and Reimbursement team at Edwards Lifesciences. Since joining in 2015, he has helped drive reimbursement, health economic, market access, evidence generation, and health policy strategies for Edward Lifesciences surgical products. During this time he has developed a wide range of economic and reimbursement collateral and messaging to support global product launches. In addition, he has successfully obtained and implemented a New Technology Add-on Payment (NTAP) for a rapid deployment surgical aortic heart valve and a new Category III CPT Code for a novel mitral repair device. Prior to Joining Edwards Lifesciences he spent 4 years at Hull Associates developing reimbursement and markets access strategies for a wide range of medical device and pharmaceutical clients. From West Lafayette Indiana originally, Matt holds Exercise Physiology and Medical Physiology degrees from the University of Indiana (’02), the University of Georgia (’04), and the University of Missouri (’08). He currently lives in Aliso Viejo, California with his wife Darcy and two daughters, Ellie and Emily.

a0d5A00000LDDOzQAP
Go

Events and Networking

Biocom Medical Device Workshop: Reimbursement Seminar and Update

Price of Admission